Skip to main content

Find Clinical Trials

Home
Conditions
Metastatic Hormonesensitive Prostate Cancer (mHSPC)

Clinical trial condition

Metastatic Hormonesensitive Prostate Cancer (mHSPC)

Explore clinical trials studying Metastatic Hormonesensitive Prostate Cancer (mHSPC). Study availability and eligibility vary by location and protocol.

1 public trial 1 recruiting study

Refine in advanced search Browse all conditions

Metastatic Hormonesensitive Prostate Cancer (mHSPC) trial results

Recruiting

An Observational Study to Learn More About How Medicines That Block Male Hormones Are Used in People With Prostate Cancer in Australia

NCT07223372

Conditions: Metastatic Hormonesensitive Prostate Cancer (mHSPC)
Locations: Bayer Pymble, New South Wales, Australia

View Trial Details